Sandbox:Sara: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(75 intermediate revisions by the same user not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{S.M.}}
{{CMG}}; {{AE}} {{S.M.}}


* Multiple [[Study design|studies]] have been [[Carrying capacity|carried]] out to find out the [[Effective method|effectiveness]] of [[sunscreen]] in [[Protecting group|protection]] against [[skin cancer]]
*'''International [[standard]] [[quantity]] of [[sunscreen]]''' application [[Usage analysis|used]] to determine [[SPF]] is '''2 mg/cm''' but mostly [[People's Solidarity|people]] apply only 0.5 to 1.5 mg/cm2 of [[sunscreen]] and don't reapply [[sunscreens]] after [[sweating]] excessively or [[swimming]]<ref name="pmid11712033">{{cite journal| author=Diffey BL| title=When should sunscreen be reapplied? | journal=J Am Acad Dermatol | year= 2001 | volume= 45 | issue= 6 | pages= 882-5 | pmid=11712033 | doi=10.1067/mjd.2001.117385 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11712033  }} </ref><ref name="urlSunscreens in the Management of Photodermatoses">{{cite web |url=https://www.skintherapyletter.com/sunscreen/photodermatoses/ |title=Sunscreens in the Management of Photodermatoses |format= |work= |accessdate=}}</ref><ref name="urlUpdate on Sunscreens">{{cite web |url=https://www.skintherapyletter.com/sunscreen/advances-update/ |title=Update on Sunscreens |format= |work= |accessdate=}}</ref>
*[[Study design|Studies]] show that photoaging mobile app [[Usage analysis|usage]] by different [[Adolescent|adolescents]] actually [[Motivation|motivates]] them to [[Avoidance response|avoid]] the [[Ultraviolet|UV]] [[Exposure (photography)|exposure]] after [[Lookahead|looking]] at their 3D selfie
* One of the [[Study design|studies]] [[Motivation|motivated]]:<ref name="urlJMU - A Skin Cancer Prevention Facial-Aging Mobile App for Secondary Schools in Brazil: Appearance-Focused Interventional Study | Brinker | JMIR mHealth and uHealth">{{cite web |url=https://mhealth.jmir.org/2018/3/e60/ |title=JMU - A Skin Cancer Prevention Facial-Aging Mobile App for Secondary Schools in Brazil: Appearance-Focused Interventional Study &#124; Brinker &#124; JMIR mHealth and uHealth |format= |work= |accessdate=}}</ref>
** 90.5% [[People's Solidarity|people]] to avoid using a [[Tanning booth|tanning bed]]
** 90.2% [[People's Solidarity|people]] to improve their [[Sun protection factor|sun protection]]
* Another [[Study design|study]] showed the positive [[Effective method|effectiveness]] of photoaging mobile app in [[Change detection|changing]] [[behavioral]] [[Prediction|predictors]] in [[Adolescent|adolescents]] with fair [[skin]] (i.e. [[Fitzpatrick scale|Fitzpatrick]] [[skin]] types 1-2)<ref name="BrinkerBrieske2017">{{cite journal|last1=Brinker|first1=Titus Josef|last2=Brieske|first2=Christian Martin|last3=Schaefer|first3=Christoph Matthias|last4=Buslaff|first4=Fabian|last5=Gatzka|first5=Martina|last6=Petri|first6=Maximilian Philip|last7=Sondermann|first7=Wiebke|last8=Schadendorf|first8=Dirk|last9=Stoffels|first9=Ingo|last10=Klode|first10=Joachim|title=Photoaging Mobile Apps in School-Based Melanoma Prevention: Pilot Study|journal=Journal of Medical Internet Research|volume=19|issue=9|year=2017|pages=e319|issn=1438-8871|doi=10.2196/jmir.8661}}</ref><ref name="BrinkerSchadendorf2017">{{cite journal|last1=Brinker|first1=Titus Josef|last2=Schadendorf|first2=Dirk|last3=Klode|first3=Joachim|last4=Cosgarea|first4=Ioana|last5=Rösch|first5=Alexander|last6=Jansen|first6=Philipp|last7=Stoffels|first7=Ingo|last8=Izar|first8=Benjamin|title=Photoaging Mobile Apps as a Novel Opportunity for Melanoma Prevention: Pilot Study|journal=JMIR mHealth and uHealth|volume=5|issue=7|year=2017|pages=e101|issn=2291-5222|doi=10.2196/mhealth.8231}}</ref>




<ref name="pmid27261907">{{cite journal| author=Mao Y, Yang D, He J, Krasna MJ| title=Epidemiology of Lung Cancer. | journal=Surg Oncol Clin N Am | year= 2016 | volume= 25 | issue= 3 | pages= 439-45 | pmid=27261907 | doi=10.1016/j.soc.2016.02.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27261907  }} </ref>


[[File:Atypical Bcell gif.gif|thumb|200px|none|High-power field of peripheral blood smear revealing a large, atypical B cell with mild cytoplasmic expansion, coarse chromatin, multiple distinct nucleoli and peripheral vacuolation.[https://openi.nlm.nih.gov/detailedresult.php?img=PMC2944189_1752-1947-4-300-2&query=waldenstrom+macroglobulinaemia&it=xg&req=4&npos=17 Source: Charakidis M. et al, Department of Haematology-Oncology, Royal Hobart Hospital, Tasmania, 7000, Australia.]]]




{|
|+'''Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders'''
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Criteria
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Symptomatic WM
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Asymptomatic WM
! style="background:#4479BA; color: #FFFFFF;" align="center" + |IgM-Related Disorders
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MGUS
|-
! align="center" style="background:#DCDCDC;" + |IgM monoclonal protein
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | +
|-
! align="center" style="background:#DCDCDC;" + |Bone marrow infiltration
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | -
| style="background:#F5F5F5;" align="center" + | -
|-
! align="center" style="background:#DCDCDC;" + |Symptoms attributable to IgM
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | -
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | -
|-
! align="center" style="background:#DCDCDC;" + |Symptoms attributable to tumor infiltration
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | -
| style="background:#F5F5F5;" align="center" + | -
| style="background:#F5F5F5;" align="center" + | -
|}<br />




==References==
 
 
 
==Reference==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 18:18, 11 December 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]


[1]

High-power field of peripheral blood smear revealing a large, atypical B cell with mild cytoplasmic expansion, coarse chromatin, multiple distinct nucleoli and peripheral vacuolation.Source: Charakidis M. et al, Department of Haematology-Oncology, Royal Hobart Hospital, Tasmania, 7000, Australia.


Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders
Criteria Symptomatic WM Asymptomatic WM IgM-Related Disorders MGUS
IgM monoclonal protein + + + +
Bone marrow infiltration + + - -
Symptoms attributable to IgM + - + -
Symptoms attributable to tumor infiltration + - - -




Reference

  1. ↑ Mao Y, Yang D, He J, Krasna MJ (2016). "Epidemiology of Lung Cancer". Surg Oncol Clin N Am. 25 (3): 439–45. doi:10.1016/j.soc.2016.02.001. PMID 27261907.
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:Sara&oldid=1678042"